Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 232-240, October 2010

Single Nucleotide Polymorphisms of DNA Repair Genes as Predictors of Radioresponse

  • Matthew B. Parliament, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Matthew Parliament, MD, Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2
  • ,
  • David Murray, PhD

Departments of Radiation and Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada

Radiation therapy is a key modality in the treatment of cancer. Substantial progress has been made in unraveling the molecular events which underpin the responses of malignant and surrounding normal tissues to ionizing radiation. An understanding of the genes involved in processes such as DNA double-strand break repair, DNA damage response, cell-cycle control, apoptosis, cellular antioxidant defenses, and cytokine production, has evolved toward examination of how genetic variants, most often, single nucleotide polymorphisms (SNPs), may influence interindividual radioresponse. Experimental approaches, such as candidate SNP-association studies, genome-wide association studies, and massively parallel sequencing are being proposed to address these questions. We present a focused review of the evidence supporting an association between SNPs in DNA repair genes and radioresponse in normal tissues and tumors. Although preliminary results indicate possible associations, there are methodological weaknesses in many of the studies, and independent validation of SNPs as biomarkers of radioresponse in much larger cohorts will likely require research cooperation through international consortia.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by an operating grant to MBP from the Alberta Cancer Research Institute, Alberta, Canada.

PII: S1053-4296(10)00037-8

doi:10.1016/j.semradonc.2010.05.003

Seminars in Radiation Oncology
Volume 20, Issue 4 , Pages 232-240, October 2010